|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010711,
umls-concept:C0020789,
umls-concept:C0023467,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0040845,
umls-concept:C0205195,
umls-concept:C0205269,
umls-concept:C0205390,
umls-concept:C1518422
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-4-17
|
|
pubmed:abstractText |
All trans retinoic acid has shown a remarkable effectiveness in acute promyelocytic leukemia. These results have encouraged studies of treatment with ATRA in other acute myeloid leukemia subtypes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1466-4860
|
|
pubmed:author |
pubmed-author:AnglaretBrunoB,
pubmed-author:ArchimbaudEricE,
pubmed-author:BelhabriAmineA,
pubmed-author:ChelghoumYoucefY,
pubmed-author:DhedinNathalieN,
pubmed-author:DombretHervéH,
pubmed-author:FièreDenisD,
pubmed-author:MichalletMauricetteM,
pubmed-author:RemanOumedalyO,
pubmed-author:ThomasXavierX,
pubmed-author:VekhoffAnneA,
pubmed-author:WattelEricE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-55
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11960396-Acute Disease,
pubmed-meshheading:11960396-Adult,
pubmed-meshheading:11960396-Aged,
pubmed-meshheading:11960396-Aged, 80 and over,
pubmed-meshheading:11960396-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11960396-Cytarabine,
pubmed-meshheading:11960396-Female,
pubmed-meshheading:11960396-Humans,
pubmed-meshheading:11960396-Idarubicin,
pubmed-meshheading:11960396-Leukemia, Myeloid,
pubmed-meshheading:11960396-Male,
pubmed-meshheading:11960396-Middle Aged,
pubmed-meshheading:11960396-Remission Induction,
pubmed-meshheading:11960396-Salvage Therapy,
pubmed-meshheading:11960396-Survival Analysis,
pubmed-meshheading:11960396-Therapeutic Equivalency,
pubmed-meshheading:11960396-Treatment Outcome,
pubmed-meshheading:11960396-Tretinoin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.
|
|
pubmed:affiliation |
Service d'Hématologie, Hôpital Edouard Herriot, Lyon, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
